Kanghua Biotech: The stock continues to be suspended from trading, and the expected suspension period will not exceed 3 trading days.

Kanghua Biotech announced on the evening of July 15th that on July 11th, 2025, the company received a notification from its controlling shareholder and actual controller, Wang Zhentao, stating that he is planning changes to the company's controlling rights, which may result in a change in the company's controlling shareholder and actual controller. As of the disclosure date of this announcement, all parties involved are actively progressing with the necessary work for this transaction. The company expects that trading of its stock will not resume on the morning of July 16th, 2025. The company's shares will remain suspended from trading starting from the morning of July 16th, 2025, and it is expected that the suspension will not last more than 3 trading days.